To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open183
High185.8
Low179.92
Prev. Close181.42
Avg. Traded Price183.01
Volume4,19,687

MARKET DEPTH

info2
Total bid3,802.00
Total ask0.00
OrdersQtyBid
93802181.42
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

179.9210 hours ago
185.8015 hours ago
arrow

LOWER/UPPER CIRCUITS

146.00
219.01
arrow
Sequent Scientific Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 13.43%, in the last year to ₹1,566.06 Cr. Its sector's average revenue growth for the last fiscal year was 10.53%.
noteAnnual Net Profit,rose 160.99% in the last year to ₹21.88 Cr. Its sector's average net profit growth for the last fiscal year was 36.7%.
noteQuarterly Revenue,rose 13.12% YoY to ₹445.29 Cr. Its sector's average revenue growth YoY for the quarter was 9.69%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 9.97%
Net profit growth 5Y CAGR : %
Sequent Scientific Ltd Top mutual funds holding
arrow
SeQuent is looking towards the future with courage and confidence because of the critical role it can play to help make a difference in global economic progress and social wellbeing. Ever since inception in 2002 SeQuent has emerged as an integrated pharmaceutical company with a global footprint operating in the domains of Animal Health (API and formulation). The company branded its Animal Health business as Alivira Animal Health with a singular focus to create value in the global animal health space. It caters to unaddressed global market requirements and focus on products for livestock poultry and companion animals.
personal

Grow your wealth with more research recommendations

+91